http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9f035cae8bbd199e54f1e6cde011e17
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Issa |
| name | Jean-Pierre J Issa Jean-Pierre J. Issa |
| given-name | Jean-Pierre J. Jean-Pierre J |
| organization-name | Authors' Affiliations: 1Lester and Sue Smith Breast Center, and Departments of Medicine, and Molecular and Cellular Biology, Baylor College of Medicine; and 2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas From the Johns Hopkins Oncology Center, Baltimore, MD; the University of New Mexico School of Medicine, Albuquerque, NM; the Southwest Oncology Group Statistical Center, Seattle, WA; and the Leukemia Department, University of Texas at MD Anderson Cancer Center, Houston, TX. Departments of Leukemia, Biostatistics, Department of Leukemia, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA Department of Molecular Biology, Cancer Research Institute, First Department of Internal Medicine, and Department of Oral Surgery, Sapporo Medical University, Sapporo 060-8556, Japan; MD Anderson Cancer Center, Houston, TX 77030; and The Johns Hopkins Oncology Center, Baltimore, MD 21231 Department of Leukemia, M.D. Anderson Cancer Center, Houston, Texas 1Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania.; 2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; and Division of Human Cancer Genetics, Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210 Authors' Affiliations: 1Fels Institute for Cancer Research & Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania; 2Department of Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville; 3Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas; 4Department of Gastroenterology, Fujita Health University School of Medicine, Toyoake; and 5Department of Gastroenterology, Kanazawa Medical University, Ishikawa, Japan 3Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas Johns Hopkins Oncology Center, Baltimore, MD 21231; and Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030 The Johns Hopkins Oncology Center, 424 North Bond Street, Baltimore, MD 21231 Authors' Affiliations: Departments of 1Leukemia, 2Molecular Carcinogenesis, and 3Bioinformatics and Computational Biology, 4Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center; and 5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas Departments ofLeukemia, Authors' Affiliations: 1Fels Institute for Cancer Research & Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania; 2Department of Gastroenterology, Fujita Health University School of Medicine, Toyoake; First Departments of 3Internal Medicine and 4Molecular Biology, Sapporo Medical University, Sapporo; 5Department of Gastroenterology, Akita Red Cross Hospital, Akita; 6Department of Pathology, Iwate Medical University, Morioka; 7Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan; 8Division of OVP, Department of Clinical Cancer Prevention, Cancer Prevention and Population Sciences; 9Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston; and 10Department of Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas From the Departments of Leukemia and Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Baylor College of Medicine and Michael DeBakey Veterans Administration Hospital, Houston, TX; and the Department of Pathophysiology, First Faculty of Medicine, Charles University, Prague, Czech Republic. 23Coriell Institute for Medical Research, Camden, NJ; From the Departments of Leukemia and Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and H. Lee Moffitt Cancer Center, Tampa, FL. The Johns Hopkins Oncology Center and The Howard Hughes Medical Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21231; National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709; Department of Medicine and Ireland Cancer Center, Case Western Reserve University, Cleveland, OH 44106; and Ludwig Institute for Cancer Research, The Cancer Center and Department of Medicine, University of California at San Diego School of Medicine, La Jolla, CA 92093 Author's Affiliation: University of Texas M.D. Anderson Cancer Center, Houston, Texas Authors' Affiliations: 1Department of Leukemia, The University of Texas M.D. Anderson Cancer Center and 2Graduate School of Biomedical Sciences, The University of Texas, Houston, Texas; Authors' Affiliations: 1Department of Leukemia, The University of Texas M.D. Anderson Cancer Center and 2Graduate School of Biomedical Sciences, The University of Texas, Houston, Texas Fels Institute, Temple University School of Medicine & Cancer Epigenetics Program, Fox Chase Cancer Center, Temple Health, 3307 North Broad Street, Room 154, Philadelphia, PA 19140, USA 1Department of Leukemia, the University of Texas M. D. Anderson Cancer Center, Houston, Texas and 1Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas and *Departments of Leukemia, Graduate School of Biomedical Sciences, MD Anderson Cancer Center 1Department of Leukemia, The University of Texas M. D. Anderson Cancer Center;; 2Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas Authors' Affiliations: 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 2Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania; Authors' Affiliations: 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 2Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania Authors' Affiliations: 1The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 2Dana-Farber Cancer Institute, Boston, Massachusetts From the Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX; and the First Department of Internal Medicine and the Department of Molecular Biology, Cancer Research Institute, Sapporo Medical University, Sapporo, Japan. From The Johns Hopkins Oncology Center, Baltimore, MD; and The MD Anderson Cancer Center, Houston, TX. Authors' Affiliations: Departments of 1Leukemia and 2Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 3Department of Gastroenterology, Showa University School of Medicine and 4Promotion Center of Pharmaceutical Education, Showa University School of Pharmacy, Tokyo, Japan; 5Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan; and 6Department of Diagnostic Pathology, St. Marianna University School of Medicine, Kanagawa, Japan 1The University of Texas M. D. Anderson Cancer Center, Houston, Texas; M.D. Anderson Cancer Center, Houston, TX, USA 4Coriell Institute for Medical Research, Camden, NJ 10School of Medicine, Temple University, Philadelphia, Pennsylvania. Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania. 3Department of Leukemia and Center for Cancer Epigenetics and 1Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania. Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston 3Oncology Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231 Authors' Affiliations: 1Department of Neurosurgery, Nagoya University School of Medicine; Divisions of 2Epigenomics and 3Molecular Oncology, Aichi Cancer Center Research Institute; 4Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences; 5Department of Scientific and Engineering Simulation, Graduate School of Engineering, Nagoya Institute of Technology; 6Department of Cancer Genetics, Nagoya University Graduate School of Medicine, Nagoya; 7Institute for Integrated Cell-Material Sciences/Institute for Chemical Research, Kyoto University, Kyoto; 8Department of Physiology, Keio University School of Medicine; 9Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency, Tokyo, Japan; 10Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, Canada; 11Medical Research Institute, Chungang University College of Medicine, Seoul, Republic of Korea; and 12Fels Institute for Cancer Re 1Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania. 2Department of Leukemia, Division of Cancer Medicine; and Divisions of 1Molecular Oncology and 2Epidemiology and Prevention, Aichi Cancer Center Research Institute; Departments of 3Cancer Genetics and 4Respiratory Medicine and 5Division of General Thoracic Surgery, Nagoya University Graduate School of Medicine; 6Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan; 7Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; 8Department of Biochemistry and 9First Department of Internal Medicine, Sapporo Medical University, Sapporo, Japan; 10Department of General Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, China; 11Department of Biomedical Sciences, Chubu University, Kasugai, Japan; and 12Department of Respiratory Medicine, Okayama Rosai Hospital, Okayama, Japan Fels Institute, Temple University, Philadelphia, PA 19140, USA. The University of Texas M.D. Anderson Cancer Center, Houston, Texas 1Leukemia and Departments of Authors' Affiliations: Departments of 1Leukemia, 2Pathology, and 3Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston; 4Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas Authors' Affiliation: Department of Leukemia and Center for Cancer Epigenetics, University of Texas M. D. Anderson Cancer Center, Houston, Texas From the Department of Leukemia and Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX Fels Institute, Temple University School of Medicine, Philadelphia, PA Authors' Affiliations: Departments of 1Head and Neck Surgery, 2Bioinformatics and Computational Biology, 3Epidemiology, 4Pediatrics, 5Pathology, and 6Systems Biology, The University of Texas MD Anderson Cancer Center; 7Human Genome Sequencing Center, 8Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas; and 9Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 5Department of Leukemia and Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 2Leukemia, From the *Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA. From the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; and SuperGen Inc, Dublin, CA. Scott Kopetz, Dipen Maru, Van Morris, Filip Janku, and Arvind Dasari, The University of Texas MD Anderson Cancer Center, Houston, TX; Emily Chan, Vanderbilt-Ingram Cancer Center, Nashville, TN; Joel Randolph Hecht, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles; Brian James and Garth Powis, Sanford Burnham Institute, La Jolla; Keith B. Nolop, Plexxikon, Berkeley; Suman Bhattacharya, Genentech, South San Francisco, CA; Peter J. O'Dwyer, Abramson Cancer Center at... Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 |
Incoming Links
Total number of triples: 244.